AccuLine

AccuLine is developing CORA, a system to help primary care physicians detect coronary artery disease through a rapid, non-invasive test. CORA integrates sensor hardware with ML-based models to provide objective, accurate assessments at the point of care. Unlike traditional cardiac diagnostics that require referrals, imaging, or stress-based evaluations, CORA is designed to be accessible, easy to use, and clinically validated for primary care settings. By enabling earlier detection and reducing unnecessary downstream testing, CORA supports timely intervention, improves clinical decision-making, and reduces overall healthcare costs. AccuLine is backed by strong investors such as eHealthventures, Macabbi Healthcare Services and Mayo Clinic.